logo-loader
NASDAQ:AVXL

Anavex Life Sciences

Receive alerts
Market:
NASDAQ
Market Cap:
$185.86 m
Price
$3.53
Change
6.65%
52 weeks high
4.08
52 weeks low
1.25

In brief

Anavex Life Sciences Corp. is a clinical-stage biopharmaceutical company engaged in the development of novel drug candidates to treat Alzheimer’s disease, other CNS diseases and various types of cancer.